Elena Geretti

1.9k total citations
30 papers, 1.5k citations indexed

About

Elena Geretti is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Elena Geretti has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Elena Geretti's work include HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). Elena Geretti is often cited by papers focused on HER2/EGFR in Cancer Research (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Nanoparticle-Based Drug Delivery (7 papers). Elena Geretti collaborates with scholars based in United States, Austria and Canada. Elena Geretti's co-authors include Michael Klagsbrun, Bart S. Hendriks, Akio Shimizu, Thomas J. Wickham, Shannon C. Leonard, Andreas J. Kungl, Helen Lee, Victor Moyo, Kathy D. Miller and Ian E. Krop and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Elena Geretti

30 papers receiving 1.5k citations

Peers

Elena Geretti
Jerónimo Blanco Spain
Lise Roth France
Jianwu Xie United States
Serena Marchiò Italy
Anna Maria Gasparri Italy
Jennifer R. Allport United States
Amy J. Eisenfeld United States
Eric A. Murphy United States
Quang‐Dé Nguyen United Kingdom
Madduri Srinivasarao United States
Jerónimo Blanco Spain
Elena Geretti
Citations per year, relative to Elena Geretti Elena Geretti (= 1×) peers Jerónimo Blanco

Countries citing papers authored by Elena Geretti

Since Specialization
Citations

This map shows the geographic impact of Elena Geretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Geretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Geretti more than expected).

Fields of papers citing papers by Elena Geretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Geretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Geretti. The network helps show where Elena Geretti may publish in the future.

Co-authorship network of co-authors of Elena Geretti

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Geretti. A scholar is included among the top collaborators of Elena Geretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Geretti. Elena Geretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumont, Nancy, Cynthia Lavoie, Vasilios Papavasiliou, et al.. (2019). Nanoliposome targeting in breast cancer is influenced by the tumor microenvironment. Nanomedicine Nanotechnology Biology and Medicine. 17. 71–81. 27 indexed citations
2.
Münster, Pamela N., Ian E. Krop, Patricia LoRusso, et al.. (2018). Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study. British Journal of Cancer. 119(9). 1086–1093. 95 indexed citations
3.
Lee, Helen, Anthony F. Shields, Barry A. Siegel, et al.. (2017). 64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer. Clinical Cancer Research. 23(15). 4190–4202. 285 indexed citations
4.
Mucka, Patrick, Elena Geretti, Bernadette Zwaans, et al.. (2016). Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency. American Journal Of Pathology. 186(11). 2803–2812. 27 indexed citations
5.
6.
Espelin, Christopher W., Shannon C. Leonard, Elena Geretti, Thomas J. Wickham, & Bart S. Hendriks. (2016). Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer. Cancer Research. 76(6). 1517–1527. 96 indexed citations
7.
Geretti, Elena, Shannon C. Leonard, Nancy Dumont, et al.. (2015). Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302). Molecular Cancer Therapeutics. 14(9). 2060–2071. 51 indexed citations
8.
Lee, Helen, Jinzi Zheng, Daniel F. Gaddy, et al.. (2014). A gradient-loadable 64Cu-chelator for quantifying tumor deposition kinetics of nanoliposomal therapeutics by positron emission tomography. Nanomedicine Nanotechnology Biology and Medicine. 11(1). 155–165. 46 indexed citations
9.
Geretti, Elena, Tanja Gerlza, James Robinson, et al.. (2013). Designing CXCL8-based decoy proteins with strong anti-inflammatory activity in vivo. Bioscience Reports. 33(5). 33 indexed citations
10.
Onsum, Matthew, Elena Geretti, Violette Paragas, et al.. (2013). Single-Cell Quantitative HER2 Measurement Identifies Heterogeneity and Distinct Subgroups within Traditionally Defined HER2-Positive Patients. American Journal Of Pathology. 183(5). 1446–1460. 72 indexed citations
11.
Reynolds, Joseph G., Elena Geretti, Bart S. Hendriks, et al.. (2012). HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity. Toxicology and Applied Pharmacology. 262(1). 1–10. 93 indexed citations
12.
Hendriks, Bart S., et al.. (2012). Multiscale Kinetic Modeling of Liposomal Doxorubicin Delivery Quantifies the Role of Tumor and Drug‐Specific Parameters in Local Delivery to Tumors. CPT Pharmacometrics & Systems Pharmacology. 1(11). 1–11. 54 indexed citations
13.
Geretti, Elena, Laurens A. van Meeteren, Akio Shimizu, et al.. (2010). A Mutated Soluble Neuropilin-2 B Domain Antagonizes Vascular Endothelial Growth Factor Bioactivity and Inhibits Tumor Progression. Molecular Cancer Research. 8(8). 1063–1073. 48 indexed citations
14.
Hoos, Sylviane, et al.. (2009). Novel svVEGF isoforms from Macrovipera lebetina venom interact with neuropilins. Biochemical and Biophysical Research Communications. 389(1). 10–15. 7 indexed citations
15.
Rek, Angelika, Barbara Brandner, Elena Geretti, & Andreas J. Kungl. (2009). A biophysical insight into the RANTES–glycosaminoglycan interaction. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(4). 577–582. 24 indexed citations
16.
Geretti, Elena, Akio Shimizu, & Michael Klagsbrun. (2008). Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis. 11(1). 31–39. 146 indexed citations
17.
Geretti, Elena & Michael Klagsbrun. (2007). Neuropilins. Cell Adhesion & Migration. 1(2). 56–61. 52 indexed citations
18.
Geretti, Elena, Akio Shimizu, Peter Kurschat, & Michael Klagsbrun. (2007). Site-directed Mutagenesis in the B-Neuropilin-2 Domain Selectively Enhances Its Affinity to VEGF165, but Not to Semaphorin 3F. Journal of Biological Chemistry. 282(35). 25698–25707. 37 indexed citations
19.
Krieger, Elmar, et al.. (2004). A structural and dynamic model for the interaction of interleukin‐8 and glycosaminoglycans: Support from isothermal fluorescence titrations. Proteins Structure Function and Bioinformatics. 54(4). 768–775. 51 indexed citations
20.
Lau, Elaine K., Chad D. Paavola, Zoë Johnson, et al.. (2004). Identification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1. Journal of Biological Chemistry. 279(21). 22294–22305. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerónimo Blanco Breakdown of academic impact, for papers by Lise Roth Breakdown of academic impact, for papers by Jianwu Xie Breakdown of academic impact, for papers by Serena Marchiò Breakdown of academic impact, for papers by Anna Maria Gasparri Breakdown of academic impact, for papers by Jennifer R. Allport Breakdown of academic impact, for papers by Amy J. Eisenfeld Breakdown of academic impact, for papers by Eric A. Murphy Breakdown of academic impact, for papers by Quang‐Dé Nguyen Breakdown of academic impact, for papers by Madduri Srinivasarao
Rankless by CCL
2026